Gerald Schrenk

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

Christoph J. Hofbauer, Shawn F. J. Whelan, Maria Hirschler et al. · Blood · 2014 · 119 citations · Full text

Pharmacy, Immunology, Antibody Engineering +12

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Peter L. Turecek, M.J. Bossard, Michael Graninger et al. · PubMed · 2012 · 96 citations

Medicine, Biotechnology, Pharmacology +13

BAX 855, a PEGylated rFVIII product with prolonged half-life

M. J. Bossard, M. Graninger, Herbert Gritsch et al. · Hämostaseologie · 2012 · 44 citations

Pharmacy, Biotechnology, Pharmacology +12

Pro‐ and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA^® in prophylactic therapy

Katalin Váradi, Srilatha Tangada, M. Loeschberger et al. · Haemophilia · 2016 · 36 citations · Full text

Medicine, Hematology, Pharmacology +17

Visualization of a protein-protein interaction at a single-molecule level by atomic force microscopy

Klaus Bonazza, Hanspeter Rottensteiner, Birgit Seyfried et al. · Analytical and Bioanalytical Chemistry · 2013 · 15 citations

Natural Sciences, Biochemistry, Biophysics +16